The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes-Reference-Cited by-同舟云学术

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes

Published:2022-09 Issue:9 Volume:4 Page:100525
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Younossi Zobair^ORCID,Aggarwal Priya,Shrestha Ichhya,Fernandes João,Johansen Pierre,Augusto Margarida^ORCID,Nair Sunita

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference62 articles.

1. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

2. Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options;Banini;Clin Med Insights Ther,2016

3. Human fatty liver disease: old questions and new insights;Cohen;Science,2011

4. The natural history of nonalcoholic fatty liver disease – an evolving view;Lindenmeyer;Clin Liver Dis,2018

5. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating liver endpoints in clinical trials of cardiovascular and kidney disease;Nature Medicine;2024-09-03

2. Nonalcoholic steatohepatitis/metabolic dysfunction–associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspective;Journal of Managed Care & Specialty Pharmacy;2024-09

3. Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis;Hepatology;2024-07-19

4. MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD;Hepatology International;2024-06-24

5. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease;Hepatology International;2024-06-15